SCHEMBL31207482

SCHEMBL31207482

Cc1cc(N)c(F)cc1-c1ccc2nsnc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN11 Q06124 2/20 0.42
TDO2 P48775 1/20 0.40
MEN1 O00255 2/20 0.38
MAPT P10636 2/20 0.38
KMT2A Q03164 2/20 0.38
TGFBR1 P36897 7/20 0.36
MAPK14 Q16539 5/20 0.36
APAF1 O14727 1/20 0.34
ALDH1A1 P00352 1/20 0.34
POLB P06746 1/20 0.34
THRB P10828 1/20 0.34
NR4A1 P22736 1/20 0.34
RECQL P46063 1/20 0.34
BLM P54132 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
BACE1 P56817 2/20 0.33
MAP4K4 O95819 2/20 0.33
ABL1 P00519 1/20 0.33
CTSD P07339 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30296178 0.82 PTPN11 (0.42) PTPN11TDO2MEN1MAPTKMT2A
SCHEMBL15690403 0.71 PTPN11 (0.56) PTPN11MEN1MAPTKMT2AAPAF1
SCHEMBL12302731 0.71 CCNC (0.40) TDO2MAP4K4
SCHEMBL31207423 0.71 CYP2A6 (0.51) TDO2ABL1PTGS2
SCHEMBL5244458 0.69 PTGS2 (0.42) TDO2MEN1MAPTKMT2ASMN1; SMN2
SCHEMBL28481934 0.69 MAPT (0.40) MAPTAPAF1ALDH1A1SMN1; SMN2TSHR
SCHEMBL3858998 0.69 PTPN11 (0.58) PTPN11TDO2MEN1MAPTKMT2A
SCHEMBL3729841 0.66 KDM1A (0.51) TDO2MAPTKMT2AALDH1A1BACE1
SCHEMBL27884914 0.65 USP7 (0.43) ALDH1A1THRBRECQLABL1TSHR
SCHEMBL13933744 0.64 HDAC1 (0.33) MAPTMAPK14ALDH1A1L3MBTL1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4702021-A1 COMPOUNDS CAPABLE OF MODULATING GPR65 Pathios Therapeutics Limited (GB) 2026-03-04 EP disclosed
WO-2024224064-A1 COMPOUNDS CAPABLE OF MODULATING GPR65 Pathios Therapeutics Limited (GB) 2024-10-31 WO disclosed